Nxera Pharma (SOLTF) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free SOLTF Stock Alerts $9.30 0.00 (0.00%) (As of 04/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Nxera Pharma Short Interest DataCurrent Short Volume2,175,400 sharesPrevious Short Volume1,996,800 sharesChange Vs. Previous Month+8.94%Dollar Volume Sold Short$22.71 millionShort Interest Ratio / Days to Cover7,251.3Last Record DateApril 15, 2024Today's Trading Volume0 sharesAverage Trading Volume2,833 sharesToday's Volume Vs. Average0% Short Selling Nxera Pharma ? Sign up to receive the latest short interest report for Nxera Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSOLTF Short Interest Over TimeSOLTF Days to Cover Over TimeSOLTF Percentage of Float Shorted Over Time Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! Nxera Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,175,400 shares $22.71 million +8.9%N/A7251.3 $10.44 3/31/20241,996,800 shares $21.02 million -7.4%N/A19968 $10.53 3/15/20242,156,300 shares $23.17 million -5.0%N/A287.5 $10.75 2/29/20242,269,300 shares $19.79 million +13.2%N/A22693 $8.72 2/15/20242,004,900 shares $17.34 million +22.3%N/A5012.3 $8.65 1/15/20241,294,200 shares $14.09 million -1.2%N/A2157 $10.89 Get the Latest News and Ratings for SOLTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,309,700 shares $13.10 million +8.2%N/A1437.6 $10.00 12/15/20231,211,000 shares $12.09 million -9.0%N/A2422 $9.98 11/30/20231,330,900 shares $13.24 million +25.3%N/A3327.3 $9.95 11/15/20231,062,100 shares $10.38 million -29.0%N/A5310.5 $9.77 10/31/20231,495,200 shares $13.35 million -6.8%N/A4984 $8.93 10/15/20231,603,600 shares $15.91 million -1.7%N/A1781.8 $9.92 9/30/20231,631,100 shares $16.64 million -6.0%N/A1812.3 $10.20 9/15/20231,735,300 shares $18.48 million -0.5%N/A2169.1 $10.65 8/31/20231,743,600 shares $20.26 million -0.8%N/A1748.9 $11.62 8/15/20231,757,400 shares $21.09 million -17.2%N/A5858 $12.00 7/31/20232,121,800 shares $27.48 million +52.4%N/A5304.5 $12.95 7/15/20231,392,500 shares $15.08 million +8.6%N/A633 $10.83 6/30/20231,281,900 shares $13.46 million -15.3%N/A145.7 $10.50 6/15/20231,513,300 shares $32.28 million -31.4%N/A1513.3 $21.33 5/31/20232,204,300 shares $49.37 million +6.7%N/A4408.6 $22.40 5/15/20232,065,500 shares $43.54 million +13.8%N/A10327.5 $21.08 4/30/20231,815,800 shares $35.92 million +19.7%N/A1513.2 $19.78 4/15/20231,516,400 shares $30.72 million +13.3%N/A3791 $20.26 3/31/20231,338,100 shares $22.68 million +3.1%N/A418.2 $16.95 3/15/20231,297,400 shares $23.56 million +19.7%N/A158.2 $18.16 2/28/20231,083,900 shares $17.61 million +1.3%N/A142.6 $16.25 2/15/20231,069,700 shares $16.63 million -5.1%N/A10697 $15.54 1/31/20231,127,500 shares $17.53 million +14.3%N/A0 $15.54 1/15/2023986,700 shares $15.34 million +27.9%N/A4933.5 $15.54 12/30/2022771,500 shares $11.99 million +1.2%N/A7715 $15.54 12/15/2022762,600 shares $8.66 million -14.9%N/A0 $11.36 11/30/2022896,200 shares $10.18 million -18.0%N/A0 $11.36 11/15/20221,093,100 shares $12.42 million -7.4%N/A0 $11.36 10/31/20221,180,100 shares $13.41 million -9.7%N/A0 $11.36 10/15/20221,306,300 shares $14.84 million -3.8%N/A0 $11.36 9/30/20221,357,200 shares $15.42 million +0.8%N/A0 $11.36 9/15/20221,346,500 shares $15.30 million -3.7%N/A0 $11.36 8/31/20221,397,800 shares $15.88 million +32.3%N/A6989 $11.36 8/15/20221,056,200 shares $13.04 million +5.9%N/A3520.7 $12.35A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. SOLTF Short Interest - Frequently Asked Questions What is Nxera Pharma's current short interest? Short interest is the volume of Nxera Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,175,400 shares of SOLTF short. Learn More on Nxera Pharma's current short interest. What is a good short interest ratio for Nxera Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SOLTF shares currently have a short interest ratio of 7,251.0. Learn More on Nxera Pharma's short interest ratio. Is Nxera Pharma's short interest increasing or decreasing? Nxera Pharma saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,175,400 shares, an increase of 8.9% from the previous total of 1,996,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Nxera Pharma stock? Short selling SOLTF is an investing strategy that aims to generate trading profit from Nxera Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nxera Pharma? A short squeeze for Nxera Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SOLTF, which in turn drives the price of the stock up even further. How often is Nxera Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SOLTF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Interest Data TRSBF Short Interest Data ABCZF Short Interest Data AGNPF Short Interest Data DRTSW Short Interest Data APLMW Short Interest Data ARTLW Short Interest Data ASPHF Short Interest Data ASCLF Short Interest Data AVCTF Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SOLTF) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace